Mieke Van Hemelrijck, Professor of Cancer Epidemiology at King’s College London, shared a post on LinkedIn:
“What an inspiring day at the Nuclear Medicine and Neuro-Oncology Meeting in Vienna!
It was a pleasure to present our ongoing work on an EORTC – European Organisation for Research and Treatment of Cancer proposal aimed at developing quality of life measurements for cancer patients undergoing radioligand therapy.
This is an exciting and much-needed step toward patient-centered innovation in nuclear medicine.
Learn more about the NMN Society.”
More posts featuring Mieke Van Hemelrijck
